| Returns | 1W : -7.6% , 1M : -19.8%,1Y : 742.6% |
| Peers & Returns | 1W | 1M | 1Y |
| BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD | -7.6% | -19.8% | 742.6% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 2.4% | 2.4% | 64.7% |
| DR REDDYS LABORATORIES LTD | 0.5% | 0.4% | 50.6% |
| DIVIS LABORATORIES LTD | 3.7% | 0.5% | 66.9% |
| CIPLA LTD | 0.4% | -1.2% | 102.3% |
| BIOCON LTD | 1.2% | 2.8% | 38.6% |
| AUROBINDO PHARMA LTD | 2% | -4.5% | 75.3% |
| LUPIN LTD | 3.7% | 2.7% | 64.9% |
| TORRENT PHARMACEUTICALS LTD | 1.3% | -2.9% | 14.9% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
-
P/E Calculated based on EPS of -2.36
[ Mar2020 - Standalone Results ] 13.18
P/B Calculated based on Book Value of 4.74
[ Mar2020 - Standalone Results ] 4.3
P/S Calculated based on Revenues of 62.738 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA 701% 215% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
